Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 121

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Role of Vitamin D in Cardiovascular Health

Reddy Vanga, Subba, Good, Mathew, Howard, Patricia A., Vacek, James L.·2010·The American Journal of Cardiology
DOI 10.1016/j.amjcard.2010.04.042
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2010.04.042

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 96

  1. DeLuca, 2004, Overview of general physiologic features and functions of vitamin D, Am J Clin Nutr, 80, 1689S, 10.1093/ajcn/80.6.1689S · DOI · Paper page
  2. Nibbelink, 2007, 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte, J Steroid Biochem Mol Biol, 103, 533, 10.1016/j.jsbmb.2006.12.099 · DOI
  3. Pilz, 2009, Vitamin D status and arterial hypertension: a systematic review, Nat Rev Cardiol, 6, 621, 10.1038/nrcardio.2009.135 · DOI · Paper page
  4. Vieth, 1999, Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety, Am J Clin Nutr, 69, 842, 10.1093/ajcn/69.5.842 · DOI · Paper page
  5. Calvo, 2004, Vitamin D fortification in the United States and Canada: current status and data needs, Am J Clin Nutr, 80, 1710S, 10.1093/ajcn/80.6.1710S · DOI · Paper page
  6. Kim, 2008, Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004), Am J Cardiol, 102, 1540, 10.1016/j.amjcard.2008.06.067 · DOI · Paper page
  7. Lee, 2008, Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?, J Am Coll Cardiol, 52, 1949, 10.1016/j.jacc.2008.08.050 · DOI · Paper page
  8. Tangpricha, 2002, Vitamin D insufficiency among free-living healthy young adults, Am J Med, 112, 659, 10.1016/S0002-9343(02)01091-4 · DOI · Paper page
  9. Harris, 2000, Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population, J Clin Endocrinol Metab, 85, 4125
  10. Looker, 2002, Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III, Bone, 30, 771, 10.1016/S8756-3282(02)00692-0 · DOI · Paper page
  11. Heaney, 2003, Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol, Am J Clin Nutr, 77, 204, 10.1093/ajcn/77.1.204 · DOI · Paper page
  12. Holick, 2008, Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D, J Clin Endocrinol Metab, 93, 677, 10.1210/jc.2007-2308 · DOI · Paper page
  13. Bischoff-Ferrari, 2006, Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes, Am J Clin Nutr, 84, 18, 10.1093/ajcn/84.1.18 · DOI · Paper page
  14. Hall, 2010, Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations, J Nutr, 140, 542, 10.3945/jn.109.115253 · DOI
  15. Stechschulte, 2009, Vitamin D: bone and beyond, rationale and recommendations for supplementation, Am J Med, 122, 793, 10.1016/j.amjmed.2009.02.029 · DOI
  16. Hathcock, 2007, Risk assessment for vitamin D, Am J Clin Nutr, 85, 6, 10.1093/ajcn/85.1.6 · DOI · Paper page
  17. Stephenson, 2009, The lack of vitamin D toxicity with megadose of daily ergocalciferol (D2) therapy: a case report and literature review, South Med J, 102, 765, 10.1097/SMJ.0b013e3181a8d1e4 · DOI
  18. Kimball, 2008, Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men, Ann Clin Biochem, 45, 106, 10.1258/acb.2007.007074 · DOI
  19. Resnick, 1986, Calcium-regulating hormones in essential hypertension, Ann Intern Med, 105, 649, 10.7326/0003-4819-105-5-649 · DOI · Paper page
  20. Krause, 1998, Ultraviolet B and blood pressure, Lancet, 352, 709, 10.1016/S0140-6736(05)60827-6 · DOI · Paper page
  21. Burgess, 1990, Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension, Am J Hypertens, 3, 903, 10.1093/ajh/3.12.903 · DOI
  22. Tarcin, 2009, Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects, J Clin Endocrinol Metab, 94, 4023, 10.1210/jc.2008-1212 · DOI · Paper page
  23. Duprez, 1994, Relationship between vitamin D3 and the peripheral circulation in moderate arterial primary hypertension, Blood Press, 3, 389, 10.3109/08037059409102292 · DOI
  24. Kristal-Boneh, 1997, Association of calcitriol and blood pressure in normotensive men, Hypertension, 30, 1289, 10.1161/01.HYP.30.5.1289 · DOI
  25. Scragg, 1995, Serum 25-hydroxycholecalciferol concentration in newly detected hypertension, Am J Hypertens, 8, 429, 10.1016/0895-7061(94)00195-H · DOI
  26. Scragg, 2007, Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey, Am J Hypertens, 20, 713, 10.1016/j.amjhyper.2007.01.017 · DOI · Paper page
  27. Sugden, 2008, Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels, Diabet Med, 25, 320, 10.1111/j.1464-5491.2007.02360.x · DOI · Paper page
  28. Pfeifer, 2001, Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women, J Clin Endocrinol Metab, 86, 1633
  29. Witham, 2009, Effect of vitamin D on blood pressure: a systematic review and meta-analysis, J Hypertens, 27, 1948, 10.1097/HJH.0b013e32832f075b · DOI · Paper page
  30. Melamed, 2008, Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004, Arterioscler Thromb Vasc Biol, 28, 1179, 10.1161/ATVBAHA.108.165886 · DOI · Paper page
  31. Targher, 2006, Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients, Clin Endocrinol (Oxf), 65, 593, 10.1111/j.1365-2265.2006.02633.x · DOI
  32. Reis, 2008, Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease, Am J Clin Nutr, 88, 1469, 10.3945/ajcn.2008.26447 · DOI
  33. Fahrleitner, 2002, Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease, J Gen Intern Med, 17, 663, 10.1046/j.1525-1497.2002.11033.x · DOI
  34. Pittas, 2007, The role of vitamin D and calcium in type 2 diabetes, J Clin Endocrinol Metab, 92, 2017, 10.1210/jc.2007-0298 · DOI · Paper page
  35. Bland, 2004, Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets, J Steroid Biochem Mol Biol, 89
  36. Zeitz, 2003, Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor, FASEB J, 17, 509, 10.1096/fj.02-0424fje · DOI · Paper page
  37. Bourlon, 1999, The de novo synthesis of numerous proteins is decreased during vitamin D3 deficiency and is gradually restored by 1, 25-dihydroxyvitamin D3 repletion in the islets of Langerhans of rats, J Endocrinol, 162, 101, 10.1677/joe.0.1620101 · DOI
  38. Maestro, 2000, Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells, Endocr J, 47, 383, 10.1507/endocrj.47.383 · DOI · Paper page
  39. Karvonen, 1998, Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia, Diabetes Care, 21, 1101, 10.2337/diacare.21.7.1101 · DOI
  40. 1999, Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus, Diabetologia, 42, 51, 10.1007/s001250051112 · DOI · Paper page
  41. Ishii, 2001, Seasonal variation of glycemic control in type 2 diabetic patients, Diabetes Care, 24, 1503, 10.2337/diacare.24.8.1503 · DOI
  42. Borissova, 2003, The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients, Int J Clin Pract, 57, 258, 10.1111/j.1742-1241.2003.tb10480.x · DOI · Paper page
  43. Chiu, 2004, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction, Am J Clin Nutr, 79, 820, 10.1093/ajcn/79.5.820 · DOI · Paper page
  44. Schwalfenberg, 2008, Vitamin D and diabetes: improvement of glycemic control with vitamin D3 repletion, Can Fam Physician, 54, 864
  45. Martini, 2006, Vitamin D status and the metabolic syndrome, Nutr Rev, 64, 479, 10.1111/j.1753-4887.2006.tb00180.x · DOI
  46. Fliser, 1997, No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects, Eur J Clin Invest, 27, 629, 10.1046/j.1365-2362.1997.1520699.x · DOI
  47. Tai, 2008, Glucose tolerance and vitamin D: effects of treating vitamin D deficiency, Nutrition, 24, 950, 10.1016/j.nut.2008.04.009 · DOI
  48. Dilmec, 2009, Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population, J Diabetes Complications, 24, 186, 10.1016/j.jdiacomp.2008.12.002 · DOI
  49. Malecki, 2003, Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population, Exp Clin Endocrinol Diabetes, 111, 505, 10.1055/s-2003-44711 · DOI
  50. Bid, 2009, Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study, Indian J Med Sci, 63, 187, 10.4103/0019-5359.53164 · DOI
  51. Danescu, 2009, Vitamin D and diabetes mellitus, Endocrine, 35, 11, 10.1007/s12020-008-9115-5 · DOI
  52. Lind, 1995, Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men, Am J Hypertens, 8, 894, 10.1016/0895-7061(95)00154-H · DOI · Paper page
  53. Heikkinen, 1997, Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy, Eur J Endocrinol, 137, 495, 10.1530/eje.0.1370495 · DOI
  54. Montagnani, 1994, Effects of pravastatin treatment on vitamin D metabolites, Clin Ther, 16, 824
  55. Perez-Castrillon, 2007, Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease, Am J Cardiol, 99, 903, 10.1016/j.amjcard.2006.11.036 · DOI
  56. Wilczek, 1994, Monitoring plasma levels of vitamin D metabolites in simvastatin (Zocor) therapy in patients with familial hypercholesterolemia [article in Czech], Cas Lek Cesk, 133, 727
  57. Yavuz, 2009, Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?, Cardiovasc Drugs Ther, 23, 295, 10.1007/s10557-009-6181-8 · DOI
  58. Guryev, 2003, A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1), Proc Natl Acad Sci U S A, 100, 14754, 10.1073/pnas.2336107100 · DOI · Paper page
  59. Oh, 2009, 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus, Circulation, 120, 687, 10.1161/CIRCULATIONAHA.109.856070 · DOI · Paper page
  60. Zittermann, 2007, Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors, Int J Vitam Nutr Res, 77, 280, 10.1024/0300-9831.77.4.280 · DOI
  61. Watson, 1997, Active serum vitamin D levels are inversely correlated with coronary calcification, Circulation, 96, 1755, 10.1161/01.CIR.96.6.1755 · DOI · Paper page
  62. Fleck, 1989, Latitude and ischaemic heart disease, Lancet, 1, 613, 10.1016/S0140-6736(89)91634-6 · DOI
  63. Kendrick, 2009, 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey, Atherosclerosis, 205, 255, 10.1016/j.atherosclerosis.2008.10.033 · DOI · Paper page
  64. Melamed, 2008, 25-hydroxyvitamin D levels and the risk of mortality in the general population, Arch Intern Med, 168, 1629, 10.1001/archinte.168.15.1629 · DOI · Paper page
  65. Wolf, 2007, Vitamin D levels and early mortality among incident hemodialysis patients, Kidney Int, 72, 1004, 10.1038/sj.ki.5002451 · DOI · Paper page
  66. Giovannucci, 2008, 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study, Arch Intern Med, 168, 1174, 10.1001/archinte.168.11.1174 · DOI · Paper page
  67. Wang, 2008, Vitamin D deficiency and risk of cardiovascular disease, Circulation, 117, 503, 10.1161/CIRCULATIONAHA.107.706127 · DOI · Paper page
  68. Pilz, 2008, Low vitamin d levels predict stroke in patients referred to coronary angiography, Stroke, 39, 2611, 10.1161/STROKEAHA.107.513655 · DOI · Paper page
  69. Pilz, 2008, Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography, J Clin Endocrinol Metab, 93, 3927, 10.1210/jc.2008-0784 · DOI · Paper page
  70. LaCroix, 2009, Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial, J Gerontol A Biol Sci Med Sci, 64, 559, 10.1093/gerona/glp006 · DOI
  71. Trivedi, 2003, Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial, BMJ, 326, 469, 10.1136/bmj.326.7387.469 · DOI · Paper page
  72. Tishkoff, 2008, Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility, Endocrinology, 149, 558, 10.1210/en.2007-0805 · DOI · Paper page
  73. Weishaar, 1990, Involvement of vitamin D3 with cardiovascular function, Am J Physiol, 258, E134
  74. Szabó, 2009, The role of vitamin D in the development of cardiac failure [article in Hungarian], Orv Hetil, 150, 1397, 10.1556/OH.2009.28674 · DOI
  75. McGonigle, 1984, Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone, Nephron, 36, 94, 10.1159/000183125 · DOI
  76. Shane, 1997, Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure, Am J Med, 103, 197, 10.1016/S0002-9343(97)00142-3 · DOI · Paper page
  77. Bahrami, 2008, Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis, Arch Intern Med, 168, 2138, 10.1001/archinte.168.19.2138 · DOI · Paper page
  78. Laguardia, 2006, Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure, Am J Med Sci, 332, 112, 10.1097/00000441-200609000-00003 · DOI
  79. Coughlin, 1997, What explains black-white differences in survival in idiopathic dilated cardiomyopathy?, J Natl Med Assoc, 89, 277
  80. Dries, 1999, Racial differences in the outcome of left ventricular dysfunction, N Engl J Med, 340, 609, 10.1056/NEJM199902253400804 · DOI · Paper page
  81. Vaccarino, 2002, Differences between African Americans and whites in the outcome of heart failure: Evidence for a greater functional decline in African Americans, Am Heart J, 143, 1058, 10.1067/mhj.2002.122123 · DOI
  82. Reusser, 2003, Adequate nutrient intake can reduce cardiovascular disease risk in African Americans, J Natl Med Assoc, 95, 188
  83. Hagstrom, 2009, Plasma parathyroid hormone and the risk of cardiovascular mortality in the community, Circulation, 119, 2765, 10.1161/CIRCULATIONAHA.108.808733 · DOI · Paper page
  84. Luboshitzky, 2009, Cardiovascular risk factors in primary hyperparathyroidism, J Endocrinol Invest, 32, 317, 10.1007/BF03345719 · DOI
  85. Yu N, T PD, Flynn Robert WV, Michael JM, Smith D, Rudman A, Graham PL. Increased mortality and morbidity in mild primary hyperparathyroid patients. Clin Endocrinol (Oxf). In press.
  86. Bell, 1985, Evidence for alteration of the vitamin D-endocrine system in obese subjects, J Clin Invest, 76, 370, 10.1172/JCI111971 · DOI · Paper page
  87. Alsafwah, 2008, Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure, Am J Med Sci, 335, 292, 10.1097/MAJ.0b013e318167b0bd · DOI
  88. Nesby-O'Dell, 2002, Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994, Am J Clin Nutr, 76, 187, 10.1093/ajcn/76.1.187 · DOI · Paper page
  89. Wolf, 2008, Impact of activated vitamin D and race on survival among hemodialysis patients, J Am Soc Nephrol, 19, 1379, 10.1681/ASN.2007091002 · DOI
  90. Zittermann, 2008, Poor outcome in end-stage heart failure patients with low circulating calcitriol levels, Eur J Heart Fail, 10, 321, 10.1016/j.ejheart.2008.01.013 · DOI
  91. Testa, 2009, Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts LVH progression in end stage renal disease (ESRD) patients, J Bone Miner Res, 25, 313, 10.1359/jbmr.090717 · DOI
  92. Park, 1999, Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism, Am J Kidney Dis, 33, 73, 10.1016/S0272-6386(99)70260-X · DOI · Paper page
  93. Schleithoff, 2006, Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial, Am J Clin Nutr, 83, 754, 10.1093/ajcn/83.4.754 · DOI · Paper page
  94. Chavan, 2007, Hypocalcemia as a cause of reversible cardiomyopathy with ventricular tachycardia, Ann Intern Med, 146, 541, 10.7326/0003-4819-146-7-200704030-00020 · DOI
  95. Vintzileos, 1985, Three fetal ponderal indexes in normal pregnancy, Obstet Gynecol, 65, 807
  96. Sood, 1995, Effect of vitamin D deficiency on electrocardiogram of rats, Indian J Exp Biol, 33, 61

Cited by

Metadata

Authors
Reddy Vanga, S., Good, M., Howard, P. A., & Vacek, J. L.
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2010-09
Volume
106
Issue
6
Pages
798-805
ISSN
0002-9149
DOI
10.1016/j.amjcard.2010.04.042
Cited by
121
References
4
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.